Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Savara Inc (SVRA)  
$4.81 0.22 (4.79%) as of 4:30 Tue 5/14


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 135,340,000
Market Cap: 650.99(M)
Last Volume: 11,363,101 Avg Vol: 11,331,682
52 Week Range: $1.94 - $5.59
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Co.'s primary program, molgramostim nebulizer solution is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor and is being developed for the treatment of autoimmune pulmonary alveolar proteinosis. Molgramostim nebulizer solution is administered once daily by inhalation via a nebulizer, the eFlow® Nebulizer System. The eFlow® Nebulizer System is a reusable electronic inhalation system. Molgramostim was also being investigated in cystic fibrosis (CF) and non-CF patients for the treatment of nontuberculous mycobacterial lung infection, a lung disorder.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 3,439,830 4,023,225
Total Buy Value $0 $0 $10,277,564 $11,106,809
Total People Bought 0 0 12 12
Total Buy Transactions 0 0 14 42
Total Shares Sold 0 187,843 187,843 187,843
Total Sell Value $0 $885,322 $885,322 $885,322
Total People Sold 0 3 3 3
Total Sell Transactions 0 3 3 3
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 179
  Page 7 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Neville Robert N Chief Executive Officer   •       •      –    2018-06-11 4 AS $12.01 $21,513 D/D (1,791) 487,956     -
   Neville Robert N Chief Executive Officer   •       •      –    2018-06-11 4 D $11.43 $60,030 D/D (5,252) 489,747     -
   Neville Robert N Chief Executive Officer   •       •      –    2018-06-11 4 OE $0.65 $60,028 D/D 92,351 494,999     -
   Jouhikainen Jaakko Taneli See Remarks   •       –      –    2018-06-08 4 AS $12.11 $31,950 D/D (2,638) 207,688     -
   Lowrance David L Chief Financial Officer   •       –      –    2018-06-08 4 AS $12.13 $8,187 D/D (675) 23,080     -
   Neville Robert N Chief Executive Officer   •       •      –    2018-06-08 4 AS $12.13 $33,212 D/D (2,737) 402,648     -
   Pikover Yuri Director   –       •      –    2018-03-29 4 B $9.00 $33,603 D/D 3,734 153,734 2.39     -
   Lowrance David L Chief Financial Officer   •       –      –    2018-02-15 4 AS $12.70 $90,129 D/D (7,000) 23,755     -
   Jouhikainen Jaakko Taneli See Remarks   •       –      –    2018-02-15 4 AS $12.75 $321,320 D/D (25,000) 210,326     -
   Neville Robert N Chief Executive Officer   •       •      –    2018-02-15 4 AS $12.84 $323,173 D/D (25,000) 405,385     -
   Lowrance David L Chief Financial Officer   •       –      –    2018-01-02 4 D $15.06 $48,779 D/D (3,239) 30,755     -
   Lowrance David L Chief Financial Officer   •       –      –    2018-01-02 4 OE $1.51 $48,160 D/D 31,894 33,994     -
   Pikover Yuri Director   –       •      –    2017-10-27 4 B $7.85 $392,500 D/D 50,000 150,000 2.39     -
   Zambon Spa 10% Owner   –       –       •   2017-06-07 3 IO $0.00 $0 I/I 0 4,693,540     -
   Neville Robert N Chief Executive Officer   •       •      –    2017-06-07 4 B $4.75 $248,188 D/D 52,250 430,385 2.81     -
   Ramsay David A Director   –       •      –    2017-06-07 4 B $4.75 $99,750 D/D 21,000 22,428 2.39     -
   Pikover Yuri Director   –       •      –    2017-06-07 4 B $4.75 $475,000 D/D 100,000 100,000 2.39     -
   Mccracken Joseph S Director   –       •      –    2017-06-07 4 B $4.75 $248,188 D/D 52,250 59,866 2.39     -
   Jouhikainen Jaakko Taneli See Remarks   •       –      –    2017-06-07 4 B $4.75 $49,875 D/D 10,500 235,326 2.74     -
   Lowrance David L Chief Financial Officer   •       –      –    2017-06-07 4 B $4.75 $9,975 D/D 2,100 2,100 2.74     -
   Pauls Matthew See Remarks   •       •      –    2017-04-27 4 OE $0.00 $0 D/D 650 650     -
   Ramsay David A Director   –       •      –    2017-04-27 4 OE $0.00 $0 D/D 1,142 23,570     -
   Serenova A/s 10% Owner   –       –       •   2017-04-27 3 IO $0.00 $0 D/D 0 1,965,400     -
   Mccracken Joseph S Director   –       •      –    2017-04-27 3 IO $0.00 $0 D/D 0 7,616     -
   Jouhikainen Jaakko Taneli See RemarksOfficer   •       –      –    2017-04-27 3 IO $0.00 $0 D/D 0 224,826     -
  179 Records found
  1  2  3  4  5  6  7  8   
  Page 7 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us